Facultad de Farmacia
Facultad
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (70)
2024
-
Association between endocrine and neuropsychological endophenotypes and gambling disorder severity
Addictive Behaviors, Vol. 153
-
Cluster analysis in gambling disorder based on sociodemographic, neuropsychological, and neuroendocrine features regulating energy homeostasis
Comprehensive Psychiatry, Vol. 128
-
Design, synthesis, and biological evaluation of tetrahydropyrimidine analogue as GSK-3β/Aβ aggregation inhibitor and anti-Alzheimer's agent
Bioorganic Chemistry, Vol. 153
-
Stepwise Structural Simplification of the Dihydroxyanthraquinone Moiety of a Multitarget Rhein-Based Anti-Alzheimer Lead to Improve Drug Metabolism and Pharmacokinetic Properties
Pharmaceutics, Vol. 16, Núm. 8
2023
-
CPT1A in AgRP neurons is required for sex-dependent regulation of feeding and thirst
Biology of Sex Differences, Vol. 14, Núm. 1
-
Plasma concentration of leptin is related to food addiction in gambling disorder: Clinical and neuropsychological implications
Journal of Behavioral Addictions, Vol. 12, Núm. 4, pp. 1019-1031
2022
-
Are Signals Regulating Energy Homeostasis Related to Neuropsychological and Clinical Features of Gambling Disorder? A Case–Control Study
Nutrients, Vol. 14, Núm. 23
-
Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease
European Journal of Medicinal Chemistry, Vol. 236
-
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease
Journal of Medicinal Chemistry, Vol. 65, Núm. 6, pp. 4909-4925
-
Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool
International Journal of Molecular Sciences, Vol. 23, Núm. 11
-
Insights into the Pharmacokinetics and In Vitro Cell‐Based Studies of the Imidazoline I2 Receptor Ligand B06
International Journal of Molecular Sciences, Vol. 23, Núm. 10
-
Structure-Based Virtual Screening and in vitro and in vivo Analyses Revealed Potent Methyltransferase G9a Inhibitors as Prospective Anti-Alzheimer's Agents
ChemMedChem, Vol. 17, Núm. 13
2021
-
Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease
European Journal of Medicinal Chemistry, Vol. 222
-
Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study
Open Forum Infectious Diseases, Vol. 8, Núm. 6
-
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects
European Journal of Medicinal Chemistry, Vol. 225
-
Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas
Biomedicine and Pharmacotherapy, Vol. 140
2020
-
Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease
Journal of Medicinal Chemistry, Vol. 63, Núm. 7, pp. 3610-3633
-
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6
Journal of Medicinal Chemistry, Vol. 63, Núm. 17, pp. 9360-9390
-
Intraoperative Human Papillomavirus Test Predicts 24-Month High-Grade Squamous Intraepithelial Lesion Recurrence Saving Costs: A Prospective Cohort Study
Journal of Lower Genital Tract Disease, Vol. 24, Núm. 4, pp. 367-371
-
Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer’s Disease
Neurotherapeutics, Vol. 17, Núm. 4, pp. 1825-1835